Registering a CAGR of 7.8% over the forecast period, the market value of Botulinum Toxin is expected to reach US$ 5400 million in the year 2027.
Botulinum toxin is a neurotoxin protein produced by the gram-positive anaerobic bacterium Clostridium botulinum. Botulinum toxin inhibits the neurotransmitter acetylcholine from axons terminating at the neuromuscular junction. This is a non-invasive cosmetic procedure used to reduce facial fine lines, creases in the forehead, wrinkles, and crow's feet, among other things.
The global market for botulinum toxin is currently being driven by a number of factors. These include the increasing demand for cosmetic procedures, expanding research and development programs to expand the use of botulinum toxin, and patients' growing preference for non-invasive or minimally invasive treatments, as well as the development of new products. A growing number of treatment indications is luring large companies to invest more in research and development, which is expected to provide growth and opportunities in the future for this market.
The continuous development and launch of novel products for improving aesthetic appeal, as well as the growing demand for minimally invasive treatments in cosmetology and therapeutic applications, are driving market demand. The use of botulinum toxin in neuromuscular therapeutics is being driven by rising incidences of movement disorders and a growing number of patients with muscle spasms. Furthermore, new clinical indications for botulinum toxin, such as the treatment of nystagmus, stridor, palatal myoclonus, scoliosis, co-spasms following brachial plexus lesions (birth-related), and gait freezing (Parkinson's disease), have aided growth in this space.
The report aspects discussed the profile of the top manufacturers of the global Botulinum Toxin market. These aspects include the financial status of major companies, trending advancements, and the entire market scenario. Growth of the report has examined Botulinum Toxin Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
The global Botulinum Toxin includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include Allergan, Ipsen (EPA: IPN), Medytox, LIBP, Merz Pharmaceuticals, US World Meds and others.
Evolus Announces Enrollment of First Patient in Phase II Clinical Study of "Extra-Strength" Dose of Jeuveau®
03/31/2022—Evolus, Inc. (NASDAQ: EOLS), a performance beauty company focused on delivering breakthrough products, has enrolled its first patient in a clinical study evaluating a "extra-strength" dose of Jeuveau® (prabotulinumtoxinA-xvfs), its flagship neurotoxin product and the first and only neurotoxin dedicated exclusively to aesthetics.
Teijin Receives New Japanese Approval for Merz's Xeomin® Botulinum Toxin Type A
June 23, 2021— Merz Therapeutics and Teijin Pharma Limited announced jointly that Teijin Pharma has received additional approval from Japan's Ministry of Health, Labor, and Welfare (MHLW) to market Xeomin® (incobotulinumtoxinA) for intramuscular injection in 50, 100, or 200 units for the treatment of lower limb spasticity.
The market is segmented based on the type, applications, companies, and regions.
By Type, it is segmented into
By Application, it is segmented into
Geographically, North America dominated with a market size of USD 2.15 billion in 2020, owing to the region's highly aware and economically stable population, as well as a comparatively higher number of procedures performed. According to the International Society of Aesthetic Plastic Surgery, approximately 1.3 million procedures were performed in the United States in 2019. The increasing number of non-invasive cosmetic procedures and new product approvals for a wide range of therapeutic indications are expected to drive market growth during the forecast period.
Europe captured the second-largest share of the market, owing to an increase in individual preference for botox surgeries in key European countries and rising research and development expenditure in Europe. According to a study conducted in the United Kingdom, women who rated their self-esteem, life satisfaction, and attractiveness as low, had few religious beliefs, and were exposed to a lot of media were more likely to get botox.
The Botulinum Toxin Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Botulinum Toxin Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Scope of the Report covers Botulinum Toxin Market with a detailed analysis of the overall scenario for the market. It also highlights the business participants’ environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background, and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Botulinum Toxin Market analysis report as it has vital details to provide about regional markets and expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how the worldwide market is working through efficient information graphics.
Report Attributes | Report Details |
Report Title | Botulinum Toxin Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Allergan, Ipsen (EPA: IPN), Medytox, LIBP, Merz Pharmaceuticals |
Forecast Period 2022 to 2027 CAGR | CAGR of 7.8% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Allergan, Ipsen, Medytox, LIBP, Merz Pharmaceuticals, US World Meds |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 92 |
Customization Available | Yes, the report can be customized as per your needs |
What is the study period of this market?
The Botulinum Toxin Market is studied from 2017 - 2027.
What is the growth rate of the Botulinum Toxin Market?
The Botulinum Toxin Market is growing at a CAGR of 7.8% over the next 5 years.
Who are the key players in Botulinum Toxin Market?
Allergan, Ipsen, Medytox, LIBP, Merz Pharmaceuticals, US World Meds
What regions does this Botulinum Toxin Market report cover?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Botulinum Toxin Market?
Botulinum Toxin Type A, Botulinum Toxin Type B
What are the major end-use applications of Botulinum Toxin Market?
Medical, Cosmetic
All our reports are custom-made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.